Immunization with Haemophilus influenzae type b-CRM197 conjugate vaccine elicits a mixed Th1 and Th2 CD4+ T cell cytokine response that correlates with the isotype of antipolysaccharide antibody

Journal of Infectious Diseases

Volumn 184, Issue 7, 2001, Pages 931-935

  Kamboj, Kulwant K ^a,c   King, Christopher L ^b   Greenspan, Neil S ^a   Kirchner, H Lester ^a   Schreiber, John R ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CD4 ANTIGEN; CROSS REACTING ANTIGEN; DIPHTHERIA TOXIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFLUENZA VACCINE; MUTANT PROTEIN;

ADULT; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BACTERIAL MEMBRANE; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFLUENZA VACCINATION; LYMPHOCYTE PROLIFERATION; MEASUREMENT; MEMORY CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CYTOKINES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; INTERLEUKINS; POLYSACCHARIDES, BACTERIAL; TH1 CELLS; TH2 CELLS; VACCINATION; VACCINES, CONJUGATE;

EID: 0035479187     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323342     Document Type: Article

References (15)

1. T cell-independent antigens type 2
2. Thymus-independent and thymus-dependent responses to polysaccharide antigens
3. Responses of children immunized with the capsular polysaccharide of Haemophilus influenzae type b
4. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG responses to Haemophilus influenzae type b capsular polysaccharide in human infants
5. Preparation, characterization and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates
6. Efficacy in infancy of oligosaccharide Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61, 080 children
7. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: Global analysis of the disease burden 25 years after the use of polysaccharide vaccine and a decade after the advent of conjugates
8. An ELISA employing Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen-binding assay
9. B- and T-cell immune responses to pneumococcal conjugate vaccines: Divergence between carrier- and polysaccharide-specific immunogenicity
10. Direct visualization of cytokine producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients
11. + human T cells following a four-step cell separation method including magnetic cell sorting (MACS)
12. Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA response
13. Functional diversity of helper T lymphocytes
14. Th1 and Th2 subsets: Paradigms lost?
15. Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized